Document is current
Any future updates will be listed below
-
Authors
Jamaly, Shabbar https://orcid.org/0000-0002-5219-1297
Redfors, Bjorn
Omerovic, Elmir
Carlsson, Lena
Karason, Kristjan
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02311231 at ClinicalTrials.govDocuments that mention this clinical trial
Prognostic significance of BMI after PCI treatment in ST-elevation myocardial infarction: a cohort study from the Swedish Coronary Angiography and Angioplasty Registry
https://doi.org/10.1136/openhrt-2020-001479
Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction
https://doi.org/10.1161/circinterventions.120.008969
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report
https://doi.org/10.1016/j.ahj.2016.02.018
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction—a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
https://doi.org/10.1016/j.ahj.2016.02.007
-
Funding
Funding for this research was provided by:
Swedish federal government under the ALF agreement (ALFGBG-932636, ALFGBG-775351, ALFGBG-633141)
- License Information
